|
SATB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.861000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.113000E-01 |
| Normal-vs-Stage2 |
3.507000E-01 |
| Normal-vs-Stage3 |
5.024100E-02 |
| Normal-vs-Stage4 |
2.087600E-01 |
| Stage1-vs-Stage2 |
4.160600E-01 |
| Stage1-vs-Stage3 |
3.533900E-02 |
| Stage1-vs-Stage4 |
2.704200E-01 |
| Stage2-vs-Stage3 |
6.369200E-01 |
| Stage2-vs-Stage4 |
9.773600E-01 |
| Stage3-vs-Stage4 |
5.648600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.386000E-01 |
| Normal-vs-AfricanAmerican |
4.306200E-01 |
| Normal-vs-Asian |
6.944800E-01 |
| Caucasian-vs-AfricanAmerican |
1.166400E-01 |
| Caucasian-vs-Asian |
6.223200E-01 |
| AfricanAmerican-vs-Asian |
2.724000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.997600E-02 |
| Normal-vs-Female |
5.475600E-01 |
| Male-vs-Female |
6.564300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.428600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.111800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.722100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.371900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.119400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.632000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.098760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.331380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.508040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.487200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.617800E-03 |
| Classical-VS-Follicular |
3.541900E-02 |
| Classical-VS-Other |
8.239200E-01 |
| Classical-VS-Normal |
9.753600E-01 |
| Tall-VS-Follicular |
4.904400E-01 |
| Tall-VS-Other |
5.359800E-01 |
| Tall-VS-Normal |
2.297600E-02 |
| Follicular-VS-Other |
6.720000E-01 |
| Follicular-VS-Normal |
9.989800E-02 |
| Other-VS-Normal |
8.584800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.107000E-01 |
| Normal-vs-N1 |
2.599600E-01 |
| N0-vs-N1 |
8.853400E-01 |
|
|
